Instituto del Corazon
Bucaramanga, Colombia
Cardiologist in Bucaramanga
Cra. 28 ## 40-11, Bucaramanga, Santander
About Instituto del Corazon
"Servicios de cardiología para pacientes adultos y pediátricos"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Instituto del Corazon
During the past decade, Instituto del Corazon conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
1993-06-01
Terminated
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
1992-05-01
Completed
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
1994-03-01
2004-08-01
Completed
25
Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
1994-06-01
Completed
470
Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed
1994-07-07
2009-12-21
Completed
482
Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
1996-03-01
Completed
324
Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
1996-01-01
2004-04-01
Completed
24
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto del Corazon" #1 sponsor was "Amaranth Medical Inc." with 3 trials, followed by "Bayer" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Newron Pharmaceuticals SPA"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Instituto del Corazon
According to Clinical.Site data, the most researched conditions in "Instituto del Corazon" are
"Coronary Artery Disease" (3 trials), "Myocardial Ischemia" (3 trials), "Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials) and "Disorder; Heart, Functional, Postoperative, Cardiac Surgery" (1 trials). Many other conditions were trialed in "Instituto del Corazon" in a lesser frequency.
Clinical Trials Intervention Types at Instituto del Corazon
Most popular intervention types in "Instituto del Corazon" are "Drug" (5 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials), "AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials) and "AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto del Corazon
The vast majority of trials in "Instituto del Corazon" are
10 trials for "All" genders.
Clinical Trials Status at Instituto del Corazon
Currently, there are NaN active trials in "Instituto del Corazon".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Instituto del Corazon,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto del Corazon, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".